Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-Arm Multi-Stage Adaptive Platform Trial (APT) for the Acute Treatment of Traumatic Brain Injury

NCT05826912 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT05826912
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05826912 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-Arm Multi-Stage Adaptive Platform Trial (APT) for the Acute Treatment of Traumatic Brain Injury
Lead sponsor
University of California, San Francisco
Phase
Phase 2
Overall status
Enrolling by invitation
Start date
August 1, 2024
Completion date
August 31, 2029
Enrollment
672 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

traumatic brain injury